Accuray (ARAY) Net Cash Flow Growth (1y) (2011 - 2026)
Accuray (ARAY) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | -564.44% |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | -394.13% |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | -31.84% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | 76.43% |
| 10 | Accuray | 28,415.89 | -38.51 Mn | 25.29 Mn | -133.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -133.16% |
| Dec 31, 2025 | -464.58% |
| Sep 30, 2025 | 174.44% |
| Mar 31, 2025 | 132.08% |
| Dec 31, 2024 | 190.88% |
| Sep 30, 2024 | 5.33% |
| Mar 31, 2024 | -7,862.81% |
| Dec 31, 2023 | 56.79% |
| Sep 30, 2023 | -100.02% |
| Mar 31, 2023 | 102.19% |
| Dec 31, 2022 | -183.47% |
| Sep 30, 2022 | 49.43% |
| Mar 31, 2022 | -177.44% |
| Dec 31, 2021 | -2.37% |
| Sep 30, 2021 | 24.26% |
| Mar 31, 2021 | 402.51% |
| Dec 31, 2020 | 76.45% |
| Sep 30, 2020 | -1,034.57% |
| Jun 30, 2020 | -24.69% |
| Mar 31, 2020 | -1,164.66% |